Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242409 · ClinicalTrials.gov registry record · Phase 2
Study of Gemcitabine and Abraxane for Pancreas Cancer
A Phase 2 study, sponsored by Georgetown University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT02242409 is a Phase 2 study that was terminated before completion, run by Georgetown University. The registered enrollment target is 4 participants.
The verdict
NCT02242409, a Phase 2 study, was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
A Phase II trial of gemcitabine plus nab-paclitaxel in the second line setting
Interventions
- DRUG Gemcitabine and Abraxane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02242409
The ClinicalTrials.gov registry entry for NCT02242409 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gemcitabine and Abraxane is the first listed.
NCT02242409 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02242409 about?
NCT02242409 is a clinical study titled "Study of Gemcitabine and Abraxane for Pancreas Cancer". A Phase II trial of gemcitabine plus nab-paclitaxel in the second line setting
What is the current status of trial NCT02242409?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2014-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02242409?
The interventions under investigation include: Gemcitabine and Abraxane (DRUG).
Who is sponsoring clinical trial NCT02242409?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.